Abstract
This study aimed at examining the mechanisms participating in excessive faecal bile acid loss in cystic fibrosis. The study was designed to define the relation between faecal fat and faecal bile acid loss in patients with and without cystic fibrosis related liver disease; to assess terminal ileal bile acid absorption by a seven day whole body retention of selenium labelled homotaurocholic acid (SeHCAT); and to determine if small intestinal bacterial overgrowth contributes to faecal bile acid loss. The study population comprised 40 patients (27 men; median age 18 years) with cystic fibrosis (n = 8) and without (n = 32) liver disease and eight control subjects. Faecal bile acid excretion was significantly higher in cystic fibrosis patients without liver disease compared with control subjects (mean (SEM) 21.5 (2.4) and 7.3 (1.2) micromoles/kg/24 hours respectively; p < 0.01) and patients with liver disease (7.9 (1.3) micromoles/kg/24 hours; p < 0.01). No correlation was found between faecal fat (g fat/24 hours) and faecal bile acid (micromoles 24 hours) excretion. Eight (33%) of cystic fibrosis patients had seven day SeHCAT retention < 10% (normal retention > 20%). SeHCAT retention in cystic fibrosis patients with liver disease was comparable with control subjects (30.0 (SEM) 8.3% v 36.8 (5.9)%; p = NS) while SeHCAT retention in cystic fibrosis patients who did not have liver disease was significantly reduced (19.9 (3.8); p < 0.05). Although evidence of small bowel bacterial overgrowth was present in 40% of patients no relation was found between breath hydrogen excretion, faecal fat, and faecal bile acid loss. The results are consistent with the presence of an abnormality in terminal ideal function in patients with cystic fibrosis who do not have liver disease and that a defect in the ileal absorption of bile acids may be a contributory factor to excessive faecal bile acid loss. Faecal bile acid loss in cystic fibrosis is unrelated to the presence of intraluminal fat or intestinal bacterial overgrowth.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bali A., Stableforth D. E., Asquith P. Prolonged small-intestinal transit time in cystic fibrosis. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1011–1013. doi: 10.1136/bmj.287.6398.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boyd G. S., Merrick M. V., Monks R., Thomas I. L. Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J Nucl Med. 1981 Aug;22(8):720–725. [PubMed] [Google Scholar]
- Colombo C., Roda A., Roda E., Piceni Sereni L., Brega A., Fugazza R., Giunta A. Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency. J Pediatr Gastroenterol Nutr. 1984 Sep;3(4):556–562. doi: 10.1097/00005176-198409000-00014. [DOI] [PubMed] [Google Scholar]
- Fondacaro J. D., Heubi J. E., Kellogg F. W. Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr Res. 1982 Jun;16(6):494–498. doi: 10.1203/00006450-198206000-00019. [DOI] [PubMed] [Google Scholar]
- Goodchild M. C., Murphy G. M., Howell A. M., Nutter S. A., Anderson C. M. Aspects of bile acid metabolism in cystic fibrosis. Arch Dis Child. 1975 Oct;50(10):769–778. doi: 10.1136/adc.50.10.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harries J. T., Muller D. P., McCollum J. P., Lipson A., Roma E., Norman A. P. Intestinal bile salts in cystic fibrosis: studies in the patient and experimental animal. Arch Dis Child. 1979 Jan;54(1):19–24. doi: 10.1136/adc.54.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kerlin P., Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988 Oct;95(4):982–988. doi: 10.1016/0016-5085(88)90173-4. [DOI] [PubMed] [Google Scholar]
- Lewis R., Gorbach S. Modification of bile acids by intestinal bacteria. Arch Intern Med. 1972 Oct;130(4):545–549. [PubMed] [Google Scholar]
- Metz G., Gassull M. A., Drasar B. S., Jenkins D. J., Blendis L. M. Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet. 1976 Mar 27;1(7961):668–669. doi: 10.1016/s0140-6736(76)92779-3. [DOI] [PubMed] [Google Scholar]
- Northfield T. C., Drasar B. S., Wright J. T. Value of small intestinal bile acid analysis in the diagnosis of the stagnant loop syndrome. Gut. 1973 May;14(5):341–347. [PMC free article] [PubMed] [Google Scholar]
- Nyhlin H., Merrick M. V., Eastwood M. A., Brydon W. G. Evaluation of ileal function using 23-selena-25-homotaurocholate, a-gamma-labeled conjugated bile acid. Initial clinical assessment. Gastroenterology. 1983 Jan;84(1):63–68. [PubMed] [Google Scholar]
- Park R. W., Grand R. J. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology. 1981 Dec;81(6):1143–1161. [PubMed] [Google Scholar]
- Roller R. J., Kern F. Minimal bile acid malabsorption and normal bile acid breath tests in cystic fibrosis and acquired pancreatic insufficiency. Gastroenterology. 1977 Apr;72(4 Pt 1):661–665. [PubMed] [Google Scholar]
- Smalley C. A., Brown G. A., Parkes M. E., Tease H., Brookes V., Anderson C. M. Reduction of bile acid loss in cystic fibrosis by dietary means. Arch Dis Child. 1978 Jun;53(6):477–482. doi: 10.1136/adc.53.6.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson G. N., Davidson G. P. In vivo bile acid uptake from terminal ileum in cystic fibrosis. Pediatr Res. 1988 Mar;23(3):323–328. doi: 10.1203/00006450-198803000-00018. [DOI] [PubMed] [Google Scholar]
- Watkins J. B., Tercyak A. M., Szczepanik P., Klein P. D. Bile salt kinetics in cystic fibrosis: influence of pancreatic enzyme replacement. Gastroenterology. 1977 Nov;73(5):1023–1028. [PubMed] [Google Scholar]
- Weber A. M., Roy C. C. Bile acid metabolism in children with cystic fibrosis. Acta Paediatr Scand Suppl. 1985;317:9–15. doi: 10.1111/j.1651-2227.1985.tb14928.x. [DOI] [PubMed] [Google Scholar]
- Weber A. M., Roy C. C., Chartrand L., Lepage G., Dufour O. L., Morin C. L., Lasalle R. Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis. Gut. 1976 Apr;17(4):295–299. doi: 10.1136/gut.17.4.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weber A. M., Roy C. C., Morin C. L., Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med. 1973 Nov 8;289(19):1001–1005. doi: 10.1056/NEJM197311082891903. [DOI] [PubMed] [Google Scholar]
- de Rooij F. W., van den Berg J. W., Sinaasappel M., Bosman-Jacobs E. P., Touw-Blommesteijn A. C. Bile acid malabsorption in cystic fibrosis; membrane vesicles, a tool for revealing the role of the ileal brush border membrane. Acta Paediatr Scand Suppl. 1985;317:28–30. doi: 10.1111/j.1651-2227.1985.tb14931.x. [DOI] [PubMed] [Google Scholar]
- de Wael J., Raaymakers C. E., Endeman H. J. Simplified quantitative determination of total fecal bile acids. Clin Chim Acta. 1977 Sep 1;79(2):465–470. doi: 10.1016/0009-8981(77)90443-0. [DOI] [PubMed] [Google Scholar]